| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.22 | 0.0002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0004 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |